Evidence map›Paper›PMID 37205546›Full record

ArticleResearch square2023

Multi-ancestry GWAS of Fuchs corneal dystrophy highlights roles of laminins, collagen, and endothelial cell regulation.

Neal Peachey, Bryan Gorman, Michael Francis, Cari Nealon, Christopher Halladay, Nalvi Duro, Kyriacos Markianos, Giulio Genovese, Pirro Hysi, Hélène Choquet and 9 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 2 countries.

Neal PeacheyLouis Stokes Cleveland VA.
Bryan GormanVA Boston Healthcare System.ORCID 0000-0002-4239-4672
Michael FrancisBooz Allen Hamilton.ORCID 0000-0002-1320-7161
Cari NealonVA Northeast Ohio Healthcare System.
Christopher HalladayProvidence VA Medical Center.
Nalvi DuroVA Boston Healthcare System.
Kyriacos MarkianosVA Boston Healthcare System.ORCID 0000-0003-0214-6014
Giulio GenoveseBroad Institute.ORCID 0000-0003-3066-5575
Pirro HysiKing's College London.ORCID 0000-0001-5752-2510
Hélène ChoquetDivision of Research, Kaiser Permanente Northern California.ORCID 0000-0001-9839-8667
Natalie AfshariUC San Diego, Shiley Eye Institute.
Yi-Ju LiDuke University.ORCID 0000-0001-6996-4834
J Michael GazianoVA Boston Healthcare System.
Adriana HungVanderbilt University Medical Center.
Wen-Chih WuProvidence VA Medical Center.
Paul GreenbergProvidence VA Medical Center.
Saiju PyarajanCenter for Data and Computational Sciences, Veterans Affairs Boston Healthcare System.ORCID 0000-0002-9047-3762
Jonathan LassCase Western Reserve University and University Hospitals Case Medical Center.
Sudha IyengarCase Western Reserve University.
VA Boston Healthcare System · USProvidence VA Medical Center · USBooz Allen Hamilton (United States) · USBroad Institute · USCase Western Reserve University · USDuke University · USKaiser Permanente · USKing's College London · GBLouis Stokes Cleveland VA Medical Center · USSmith-Kettlewell Eye Research Institute · USUniversity Hospitals Cleveland Medical Center · USVanderbilt University Medical Center · USVA Northeast Ohio Healthcare System · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Irina A Pikuleva · 1997 to 2026
$17.7M
RESOURCE/SERVICE CORE C - MOLECULAR INFORMATICS MODULEP30EY025585 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI Brian D Perkins · 2016 to 2026
$7.7M
Genetics of CKD and Hypertension-Risk Prediction and Drug Response in the MVPI01CX001897 · VA · VETERANS HEALTH ADMINISTRATION · PI Adriana Hung · 2020 to 2026
–
BLRD VA I01 BX003364CSRD VA I01 CX001897NCATS NIH HHS UL1 TR002548NEI NIH HHS P30 EY011373NEI NIH HHS P30 EY025585
6 · The paper itself

Abstract

Fuchs endothelial corneal dystrophy (FECD) is a leading indication for corneal transplantation, but its molecular pathophysiology remains poorly understood. We performed genome-wide association studies (GWAS) of FECD in the Million Veteran Program (MVP) and meta-analyzed with the previous largest FECD GWAS, finding twelve significant loci (eight novel). We further confirmed the TCF4 locus in admixed African and Hispanic/Latino ancestries, and found an enrichment of European-ancestry haplotypes at TCF4 in FECD cases. Among the novel associations are low frequency missense variants in laminin genes LAMA5 and LAMB1 which, together with previously reported LAMC1, form laminin-511 (LM511). AlphaFold 2 protein modeling suggests that mutations at LAMA5 and LAMB1 may destabilize LM511 by altering inter-domain interactions or extracellular matrix binding. Finally, phenome-wide association scans and co-localization analyses suggest that the TCF4 CTG18.1 trinucleotide repeat expansion leads to dysregulation of ion transport in the corneal endothelium and has pleiotropic effects on renal function.

Identifiers

PMID37205546
PMCPMC10187421
OpenAlexW4367849670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.